If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 410.00
Bid: 390.00
Ask: 430.00
Change: 0.00 (0.00%)
Spread: 40.00 (10.256%)
Open: 410.00
High: 410.00
Low: 410.00
Prev. Close: 410.00
CRPR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorship Change

10 Aug 2022 07:00

RNS Number : 4694V
Cropper(James) PLC
10 August 2022
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

 

10 August 2022

 

James Cropper PLC (the "Company" or the "Group")

(AIM: CRPR)

 

Directorship Change

 

James Cropper PLC, the leading advanced materials and paper products group, is pleased to announce the appointment of Steve Adams as Chief Executive Officer following the resignation of Phil Wild. These changes are with immediate effect.

 

Steve Adams, who is an Executive Director of the Company and Managing Director of the James Cropper Paper Division, joined the Company in 2017 and has a strong commercial background with leadership experience previously gained at 3M in the UK and Europe covering display, traffic and vehicle safety, telecommunications, electronics and energy markets.  

 

Mark Cropper, Chair, paid tribute to the contribution which Phil Wild has made to the business over the past 10 years:

 "Under Phil's leadership, the foundations and prospects of the Group have been transformed. He has overseen step changes in TFP including the acquisition leading to TFP Hydrogen, the creation of Colourform, and the renewal of many of our functions. He has also successfully navigated us through Covid and other challenges and leaves a legacy - not least the team he built around him including Steve - that will be felt for many years to come." 

 

Commenting on his appointment, Steve Adams said:

 

"I am delighted and honoured to have been invited to lead James Cropper at a real inflection point on our growth journey. Building on the strong foundations set in place by Phil Wild, I am excited at the prospect of capitalising on the unique and significant capabilities of our people and know-how to become a truly global market leader in our core technology areas. Our Purpose and Values will continue to sit at the heart of everything we do as we position ourselves more prominently and meaningfully in front of our customers."

 

 

Enquiries:

Mark Cropper, Chair

Robert Finlay, Henry Willcocks, John More

James Cropper PLC

Shore Capital

Telephone: +44 (0) 1539 722002

Telephone: + 44 (0) 20 7408 4090

www.jamescropper.com

 

 

LEI: 213800XM78VTDYGBRM93

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADZGGRVLKGZZM
Date   Source Headline
12th Jan 20227:00 amRNSDirector/PDMR Shareholding
26th Nov 20217:00 amRNSDirector/PDMR Shareholding
23rd Nov 20217:00 amRNSDirector/PDMR Shareholding
10th Nov 20215:57 pmRNSRecord Date
9th Nov 20217:00 amRNSDirectorate Change
9th Nov 20217:00 amRNSHalf-year Report
4th Nov 20217:00 amRNSDirectorate Change
24th Sep 20211:44 pmRNSDirector/PDMR Shareholding
9th Sep 20215:35 pmRNSDirector/PDMR Shareholding
12th Aug 20217:00 amRNSGrant of Awards under Long Term Incentive Plan
5th Aug 20217:00 amRNSDirector/PDMR Shareholding
4th Aug 20217:00 amRNSDirector/PDMR Shareholding
28th Jul 202111:00 amRNSAGM Statement and Trading Update
27th Jul 202110:27 amRNSDirector/PDMR Shareholding
23rd Jul 20219:52 amRNSDirector/PDMR Shareholding
23rd Jul 20217:00 amRNSUpdate for visitors to the AGM
21st Jul 20217:00 amRNSDirector/PDMR Shareholding
6th Jul 20217:46 amRNSDirector/PDMR Shareholding
1st Jul 20212:30 pmRNSHolding(s) in Company
22nd Jun 20218:36 amRNSDirectorate Change
22nd Jun 20217:00 amRNSFinal Results
29th Mar 20217:00 amRNSDirector Dealing
25th Mar 20217:00 amRNSDirector/PDMR Shareholding
15th Mar 20219:31 amRNSDirector/PDMR Shareholding
8th Mar 20217:00 amRNSTrading Update
18th Jan 20217:00 amRNSAcquisition
18th Dec 202011:05 amRNSDirector/PDMR Shareholding
24th Nov 20207:00 amRNSDirector/PDMR Shareholding
17th Nov 20202:06 pmRNSSecond Price Monitoring Extn
17th Nov 20202:00 pmRNSPrice Monitoring Extension
10th Nov 20207:00 amRNSHalf-year Report
5th Aug 20207:00 amRNSGrant of Awards under Long Term Incentive Plan
31st Jul 20207:00 amRNSDirector/PDMR Shareholding
30th Jul 20209:41 amRNSResult of AGM
29th Jul 20207:00 amRNSAGM Statement and Trading Update
27th Jul 20201:47 pmRNSDirector/PDMR Shareholding
27th Jul 20209:00 amRNSDirectorate Change
23rd Jun 20207:00 amRNSFinal Results
1st May 20207:00 amRNSYear end and COVID 19 trading update
24th Mar 20203:57 pmRNSCOVID 19 update
20th Feb 20209:45 amRNSDirector Dealing
14th Feb 202010:13 amRNSDirector Dealing
30th Jan 20208:55 amRNSDirector/PDMR Shareholding
24th Jan 20204:30 pmRNSDirector/PDMR Shareholding
21st Jan 20202:00 pmRNSHolding(s) in Company
13th Jan 202011:05 amRNSDirector/PDMR Shareholding
17th Dec 201912:24 pmRNSDirector/PDMR Shareholding
13th Dec 20197:00 amRNSDirectors' Dealings
29th Nov 201910:42 amRNSDirector/PDMR Shareholding
19th Nov 20197:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.